Senores Pharma Wins US FDA Approval for Deferiprone Tablets, Launched by Dr Reddy's
Senores Pharmaceuticals has announced the approval and US launch of Deferiprone Tablets USP (500 mg and 1000 mg), to be marketed by Dr Reddy’s Laboratories Inc.
Senores Pharmaceuticals Ltd | 15/12/2025 | By News Bureau
Senores Pharma Subsidiary Acquires Stake in Zoraya Pharmaceuticals
The acquisition of stakes in Zoraya Pharmaceuticals marks Senores Pharma’s strategic expansion in the US market through its wholly owned subsidiary.
Senores Pharmaceuticals Ltd | 06/11/2025 | By Dineshwori | 231
Senores Pharmaceuticals Appoints Manohar Lalge as President - Research & Development
Senores Pharmaceuticals Ltd. (SPL) has appointed Manohar Lalge as President – Research and Development.
Senores Pharmaceuticals Ltd | 20/08/2025 | By Dineshwori | 215
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy